Corporate governance report not applicable for quarter ended 30 September 2026, SME Platform listing
KMS Medisurgi has told BSE that it does not need to file a corporate governance report for the quarter ended 30 September 2026.
By ScoutQuest · · 2 min read
- Quarter
- quarter ended 30 September 2026
- Scrip Code
- 540468
- Exemption Regulation
- Regulation 15(2)
What the company said
KMS Medisurgi Ltd has written to BSE stating that it is not required to disclose a Report on Corporate Governance under Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended 30th September, 2026.
Why the report is not applicable
- The company's shares are listed on the BSE SME Platform.
- Regulation 15(2) exempts a listed entity which has listed its specified securities on the SME Exchange from the corporate governance provisions specified in regulations 17, 17A, 18, 19, 20, 21, 22, 23, 24, 24A, 25, 26 and 27, clauses (b) to (i) and (t) of sub-regulation (2) of regulation 46, and paragraphs C, D and E of Schedule V.
- The same regulation also covers a listed entity having paid up equity share capital not exceeding rupees ten crore and net worth not exceeding rupees twenty five crore, as on the last day of the previous financial year.
What a corporate governance report normally contains
- Details of the board of directors and its composition.
- Meetings of the board and its committees, and attendance.
- Other governance disclosures required under the LODR Regulations.
Because the SME Platform exemption applies, these disclosures are not being shared in this report for the September 2026 quarter.
The letter
- It is addressed to BSE Limited and refers to Scrip Code 540468.
- It is signed by Siddharth Kanakia, Managing Director (DIN: 07595098), and dated 19.10.2026.
- The company has requested the exchange to take the intimation on record.
How to read this
This is a compliance intimation about which disclosures apply to the company, not an operational or financial update. The exemption it refers to is tied to the company's listing on the BSE SME Platform.
Also from KMS Medisurgi
Independent Director ceases on completion of second term
1 Oct 2026
Independent Director Ceases on Completion of Second Term
1 Oct 2026
More numbers
- Paid up equity share capital threshold under Regulation 15(2)rupees ten crore
- Net worth threshold under Regulation 15(2)rupees twenty five crore
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.